Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reza Mehran

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2017
Long-Term Survival Outcomes of Cancer-Directed Surgery for Malignant Pleural Mesothelioma: Propensity Score Matching AnalysisDavid B Nelson, David C Rice, Jiangong Niu, et al.
Plos One|June 9, 2015
Exogenous Restoration of TUSC2 Expression Induces Responsiveness to Erlotinib in Wildtype Epidermal Growth Factor Receptor (EGFR) Lung Cancer Cells through Context Specific Pathways Resulting in Enhanced Therapeutic EfficacyBingbing Dai, Shaoyu Yan, Humberto Lara-Guerra, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 10, 2018
Biomarker-Integrated Neoadjuvant Dasatinib Trial in Resectable Malignant Pleural MesotheliomaAnne S Tsao, Heather Lin, Brett W Carter, et al.
Annals of Surgery|June 20, 2017
Recurrence Risk Stratification After Preoperative Chemoradiation of Esophageal AdenocarcinomaMian Xi, Christopher L Hallemeier, Kenneth W Merrell, et al.
Clinical Lung Cancer|February 25, 2020
Locoregional Control, Overall Survival, and Disease-Free Survival in Stage IIIA (N2) Non-Small-Cell Lung Cancer: Analysis of Resected and Unresected PatientsRavi Rajaram, Arlene M Correa, Ting Xu, et al.
International Journal of Radiation Oncology, Biology, Physics|December 28, 2017
Comparative Outcomes After Definitive Chemoradiotherapy Using Proton Beam Therapy Versus Intensity Modulated Radiation Therapy for Esophageal Cancer: A Retrospective, Single-Institutional AnalysisMian Xi, Cai Xu, Zhongxing Liao, et al.
Annals of Surgical Oncology|December 10, 2025
Hepatectomy Plus Chemotherapy or Chemotherapy Alone for Resectable Liver and Unresectable Lung Metastases from Colorectal Adenocarcinoma (LUNA): A Randomized Phase II TrialIan W Folkert, Reza Mehran, Ryan Sun, et al.
Cancers|April 13, 2024
Chemotherapy Plus Atezolizumab Pre- and Post-Resection in Localized Esophageal or Gastroesophageal Junction Adenocarcinomas: A Phase I/II Single-Arm StudyMatheus Sewastjanow-Silva, Lianchun Xiao, Graciela N Gonzalez, et al.
Head & Neck|December 16, 2022
Clinical outcomes of combined cervical and transthoracic surgical approaches in patients with advanced thyroid cancerJared A Shenson, Mark E Zafereo, Mark Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2020
Evolution of Genomic and T-cell Repertoire Heterogeneity of Malignant Pleural Mesothelioma Under Dasatinib TreatmentRunzhe Chen, Won-Chul Lee, Junya Fujimoto, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2017
Long-Term Survival Outcomes of Cancer-Directed Surgery for Malignant Pleural Mesothelioma: Propensity Score Matching AnalysisDavid B Nelson, David C Rice, Jiangong Niu, et al.
Plos One|June 9, 2015
Exogenous Restoration of TUSC2 Expression Induces Responsiveness to Erlotinib in Wildtype Epidermal Growth Factor Receptor (EGFR) Lung Cancer Cells through Context Specific Pathways Resulting in Enhanced Therapeutic EfficacyBingbing Dai, Shaoyu Yan, Humberto Lara-Guerra, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 10, 2018
Biomarker-Integrated Neoadjuvant Dasatinib Trial in Resectable Malignant Pleural MesotheliomaAnne S Tsao, Heather Lin, Brett W Carter, et al.
Annals of Surgery|June 20, 2017
Recurrence Risk Stratification After Preoperative Chemoradiation of Esophageal AdenocarcinomaMian Xi, Christopher L Hallemeier, Kenneth W Merrell, et al.
Clinical Lung Cancer|February 25, 2020
Locoregional Control, Overall Survival, and Disease-Free Survival in Stage IIIA (N2) Non-Small-Cell Lung Cancer: Analysis of Resected and Unresected PatientsRavi Rajaram, Arlene M Correa, Ting Xu, et al.
International Journal of Radiation Oncology, Biology, Physics|December 28, 2017
Comparative Outcomes After Definitive Chemoradiotherapy Using Proton Beam Therapy Versus Intensity Modulated Radiation Therapy for Esophageal Cancer: A Retrospective, Single-Institutional AnalysisMian Xi, Cai Xu, Zhongxing Liao, et al.
Annals of Surgical Oncology|December 10, 2025
Hepatectomy Plus Chemotherapy or Chemotherapy Alone for Resectable Liver and Unresectable Lung Metastases from Colorectal Adenocarcinoma (LUNA): A Randomized Phase II TrialIan W Folkert, Reza Mehran, Ryan Sun, et al.
Cancers|April 13, 2024
Chemotherapy Plus Atezolizumab Pre- and Post-Resection in Localized Esophageal or Gastroesophageal Junction Adenocarcinomas: A Phase I/II Single-Arm StudyMatheus Sewastjanow-Silva, Lianchun Xiao, Graciela N Gonzalez, et al.
Head & Neck|December 16, 2022
Clinical outcomes of combined cervical and transthoracic surgical approaches in patients with advanced thyroid cancerJared A Shenson, Mark E Zafereo, Mark Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2020
Evolution of Genomic and T-cell Repertoire Heterogeneity of Malignant Pleural Mesothelioma Under Dasatinib TreatmentRunzhe Chen, Won-Chul Lee, Junya Fujimoto, et al.
Pageof 7